GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » E10

Duopharma Biotech Bhd (XKLS:7148) E10 : RM0.07 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Duopharma Biotech Bhd's adjusted earnings per share data for the three months ended in Dec. 2023 was RM0.009. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is RM0.07 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-14), Duopharma Biotech Bhd's current stock price is RM1.23. Duopharma Biotech Bhd's E10 for the quarter that ended in Dec. 2023 was RM0.07. Duopharma Biotech Bhd's Shiller PE Ratio of today is 17.57.

During the past 13 years, the highest Shiller PE Ratio of Duopharma Biotech Bhd was 28.31. The lowest was 15.86. And the median was 20.14.


Duopharma Biotech Bhd E10 Historical Data

The historical data trend for Duopharma Biotech Bhd's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd E10 Chart

Duopharma Biotech Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.07 0.07 0.07

Duopharma Biotech Bhd Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.07 0.07 0.07

Competitive Comparison of Duopharma Biotech Bhd's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duopharma Biotech Bhd's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Shiller PE Ratio falls into.



Duopharma Biotech Bhd E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Duopharma Biotech Bhd's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.009/129.4194*129.4194
=0.009

Current CPI (Dec. 2023) = 129.4194.

Duopharma Biotech Bhd Quarterly Data

per share eps CPI Adj_EPS
201403 0.014 99.695 0.018
201406 0.017 100.560 0.022
201409 0.020 100.428 0.026
201412 0.018 99.070 0.024
201503 0.021 99.621 0.027
201506 0.013 100.684 0.017
201509 0.017 100.392 0.022
201512 0.015 99.792 0.019
201603 0.009 100.470 0.012
201606 0.005 101.688 0.006
201609 0.007 101.861 0.009
201612 0.010 101.863 0.013
201703 0.011 102.862 0.014
201706 0.026 103.349 0.033
201709 0.013 104.136 0.016
201712 0.014 104.011 0.017
201803 0.012 105.290 0.015
201806 0.012 106.317 0.015
201809 0.014 106.507 0.017
201812 0.016 105.998 0.020
201903 0.016 107.251 0.019
201906 0.016 108.070 0.019
201909 0.017 108.329 0.020
201912 0.013 108.420 0.016
202003 0.015 108.902 0.018
202006 0.016 108.767 0.019
202009 0.015 109.815 0.018
202012 0.017 109.897 0.020
202103 0.019 111.754 0.022
202106 0.016 114.631 0.018
202109 0.018 115.734 0.020
202112 0.018 117.630 0.020
202203 0.022 121.301 0.023
202206 0.017 125.017 0.018
202209 0.017 125.227 0.018
202212 0.018 125.222 0.019
202303 0.024 127.348 0.024
202306 0.013 128.729 0.013
202309 0.009 129.860 0.009
202312 0.009 129.419 0.009

Add all the adjusted EPS together and divide 10 will get our e10.


Duopharma Biotech Bhd  (XKLS:7148) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Duopharma Biotech Bhd's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.23/0.07
=17.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Duopharma Biotech Bhd was 28.31. The lowest was 15.86. And the median was 20.14.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Duopharma Biotech Bhd E10 Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd (XKLS:7148) Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines